Recital 5, Decision_act (EU) 2025/2429

In forcesince 24 Nov 2025

Therefore, the areas listed as protection and surveillance zones in France, currently set out in Annex I to Implementing Decision (EU) 2025/1708, should be amended both spatially and temporally, in order to prevent the further spread of infection with lumpy skin disease virus in France and to the rest of the Union. Accordingly, it is necessary to amend the list of restricted zones, and the duration of the measures to be applied therein, set out in Annex I to that Implementing Decision. The size of the areas indicated as protection and surveillance zones, and the duration of the measures to be applied therein, are based on the criteria laid down in Article 64(1) of Regulation (EU) 2016/429 as well as on the rules laid down in Delegated Regulation (EU) 2020/687. The criteria applied for the choice of the size of the protection and surveillance zones, as well as of the duration of the measures to be applied therein, include a consideration of not only the epidemiological situation as regards infection with lumpy skin disease virus in the areas affected by that disease, but also of other epidemiological factors, including geographical parameters and the risk for the further spread of the disease in view of the presence of insect vectors. The chosen duration of the measures provided for in this Decision has also taken into account the international standards of the Terrestrial Animal Health Code of the World Organisation for Animal Health [https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/.].